Lee & Man Chemical Company Limited (0746.HK)
HKD 3.67
(-1.61%)
HKD 3.67
(-1.61%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 597.01 Million HKD | -63.3% |
| 2022 | 1.51 Billion HKD | -10.26% |
| 2021 | 1.71 Billion HKD | 170.12% |
| 2020 | 743.82 Million HKD | -30.23% |
| 2019 | 975.3 Million HKD | -30.12% |
| 2018 | 1.29 Billion HKD | 32.83% |
| 2017 | 1.04 Billion HKD | 146.03% |
| 2016 | 390.86 Million HKD | -8.21% |
| 2015 | 400.3 Million HKD | -24.73% |
| 2014 | 601.94 Million HKD | 55.95% |
| 2013 | 352.04 Million HKD | -37.36% |
| 2012 | 564.93 Million HKD | -30.23% |
| 2011 | 803.94 Million HKD | 24.86% |
| 2010 | 526.63 Million HKD | 98.38% |
| 2009 | 326.32 Million HKD | 138.19% |
| 2008 | 137.59 Million HKD | 14.43% |
| 2007 | 119.33 Million HKD | 3.93% |
| 2006 | 114.82 Million HKD | 0.0% |
| 2004 | 133.52 Million HKD | 8.12% |
| 2003 | 123.49 Million HKD | -11.46% |
| 2002 | 139.48 Million HKD | 61.0% |
| 2001 | 86.63 Million HKD | -0.54% |
| 2000 | 87.1 Million HKD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 307.3 Million HKD | 0.0% |
| 2023 Q4 | 370.51 Million HKD | 0.0% |
| 2023 FY | - HKD | -63.3% |
| 2023 Q2 | 333.36 Million HKD | 0.0% |
| 2022 Q2 | 1.08 Billion HKD | 0.0% |
| 2022 FY | - HKD | -10.26% |
| 2022 Q4 | 382.15 Million HKD | 0.0% |
| 2021 Q2 | 701.27 Million HKD | 0.0% |
| 2021 FY | - HKD | 170.12% |
| 2021 Q4 | 931.29 Million HKD | 0.0% |
| 2020 Q2 | 218.26 Million HKD | 0.0% |
| 2020 FY | - HKD | -30.23% |
| 2020 Q4 | 386.12 Million HKD | 0.0% |
| 2019 Q2 | 438.56 Million HKD | 0.0% |
| 2019 FY | - HKD | -30.12% |
| 2019 Q4 | 427.69 Million HKD | 0.0% |
| 2018 Q2 | 846.04 Million HKD | 0.0% |
| 2018 FY | - HKD | 32.83% |
| 2018 Q4 | 393.65 Million HKD | 0.0% |
| 2017 FY | - HKD | 146.03% |
| 2017 Q2 | 473.88 Million HKD | 0.0% |
| 2017 Q4 | 459.39 Million HKD | 0.0% |
| 2016 Q2 | 237.97 Million HKD | 0.0% |
| 2016 Q4 | 141.35 Million HKD | 0.0% |
| 2016 FY | - HKD | -8.21% |
| 2015 Q2 | 251.42 Million HKD | 0.0% |
| 2015 FY | - HKD | -24.73% |
| 2015 Q4 | 161.82 Million HKD | 0.0% |
| 2014 Q4 | 323.65 Million HKD | 0.0% |
| 2014 Q2 | 225.38 Million HKD | 0.0% |
| 2014 FY | - HKD | 55.95% |
| 2013 Q4 | 212.43 Million HKD | 0.0% |
| 2013 FY | - HKD | -37.36% |
| 2013 Q2 | 139.61 Million HKD | 0.0% |
| 2012 Q3 | 87.17 Million HKD | 0.0% |
| 2012 Q2 | - HKD | 0.0% |
| 2012 FY | - HKD | -30.23% |
| 2012 Q4 | - HKD | -100.0% |
| 2011 FY | - HKD | 24.86% |
| 2011 Q4 | - HKD | 0.0% |
| 2011 Q2 | - HKD | 0.0% |
| 2010 FY | - HKD | 98.38% |
| 2010 Q2 | - HKD | 0.0% |
| 2010 Q4 | - HKD | 0.0% |
| 2009 FY | - HKD | 138.19% |
| 2009 Q4 | - HKD | 0.0% |
| 2008 FY | - HKD | 14.43% |
| 2008 Q4 | - HKD | 0.0% |
| 2007 FY | - HKD | 3.93% |
| 2006 FY | - HKD | 0.0% |
| 2004 FY | - HKD | 8.12% |
| 2003 FY | - HKD | -11.46% |
| 2002 FY | - HKD | 61.0% |
| 2001 FY | - HKD | -0.54% |
| 2000 FY | - HKD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Wai Chun Bio-Technology Limited | 14.89 Million HKD | -3908.709% |